BioSpace Movers & Shakers, Jan. 1
The Pharma Data
DECEMBER 31, 2020
Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,
52 
Let's personalize your content